Intelligent Bio Solutions (INBS) Prices $4M Underwritten Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Intelligent Bio Solutions Inc. Announces Pricing of $4,000,000 Underwritten Public Offering
October 2, 2023 8:32 AM EDTNEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the Company), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of an underwritten public offering of units (the Units) for gross proceeds of approximately $4.0 million.
Ladenburg Thalmann & Co. Inc. is acting as the sole bookrunning manager for the offering.
The underwritten public offering consists of 7,272,727 shares of common stock, par value $0.01 per share, of the Company (the Common Stock) (or shares of the Companys Series E Convertible Preferred Stock (the... More
